Zhongchao (NASDAQ:ZCMD) Upgraded at Wall Street Zen

by · The Markets Daily

Wall Street Zen upgraded shares of Zhongchao (NASDAQ:ZCMD – Free Report) from a sell rating to a hold rating in a research note published on Saturday,Wall Street Zen reports.

Separately, Weiss Ratings lowered Zhongchao from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday, September 25th. One analyst has rated the stock with a Sell rating, According to MarketBeat, Zhongchao presently has a consensus rating of “Sell”.

Get Our Latest Stock Analysis on ZCMD

Zhongchao Price Performance

ZCMD opened at $1.91 on Friday. The stock has a fifty day moving average price of $1.89 and a 200 day moving average price of $119.30. Zhongchao has a 1 year low of $1.42 and a 1 year high of $1,934.40.

Zhongchao Company Profile

(Get Free Report)

Zhongchao Inc is a China-based healthcare services company that provides medical education and patient-management services. The company focuses on supporting healthcare professionals and patients through digital platforms, educational programs and related healthcare resources.

Its business activities have included continuing medical education for physicians and other medical professionals, as well as disease-management and patient-support services. Zhongchao has particularly emphasized oncology-related healthcare education and management, helping connect medical information, professional training and patient services.

The company primarily serves the healthcare market in China through online and offline offerings.

Featured Stories